Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
A. O. Olukoya, H. Stires, S. Bahnassy, S. Persaud, Y. Guerra, S. Ranjit, S. Ma, M. I. Cruz, C. Benitez, A. M. Rozeboom, H. Ceuleers, D. L. Berry, B. M. Jacobsen, G. V. Raj, R. B. Riggins
This study shows Riluzole reduces growth and improves response to endocrine therapy in ER+ breast cancer models.
bioRxiv · Jul 30, 2020 · PreprintCancer Biology